In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
How the Alcohol Industry Steers Governments Away From Effective Strategies to Curb Drink…
Analysis of the Efficacy of Alcohol Industry-Sponsored Drink-Driving Campaigns
Messaging Recommendations for Effective Road Safety Campaigns: Lessons From Formative Research for Drink…
Testimonials: Personal stories that have the power to save lives on the road
Knowledge, Attitudes, and Practice Study on Lead Poisoning and Pollution in Indonesia
Improving Civil Registration and Vital Statistics Systems in French-Speaking Countries: Opportunities and Challenges
Strengthening the Civil Registration and Vital Statistics (CRVS) System in Colombia
Estimation of the direct and indirect costs attributable to alcohol consumption in Brazil
Guidance for Collection and Processing of Cause-of-Death Data in the Civil Registration and…
Vital Strategies: Reimagine Public Health